Manfred Schmidt
Impact in
- Genetics top 0.05%
- Virus-based gene therapy research
- Hemoglobinopathies and Related Disorders
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation
Papers in
- Genetics 170
- Virus-based gene therapy research 168
- Hemoglobinopathies and Related Disorders 11
- Hematology 19
- Hematopoietic Stem Cell Transplantation 17
- Co-authors
- Christof V. Kalle (104 shared papers)Cynthia C. Bartholomae (35 shared papers)Hanno Glimm (35 shared papers)Salima Hacein‐Bey‐Abina (7 shared papers)Ali Nowrouzi (17 shared papers)Alain Fischer (6 shared papers)Marina Cavazzana (8 shared papers)Luigi Naldini (11 shared papers)
- Journals
- Molecular Therapy (33 papers)Blood (25 papers)Human Gene Therapy (16 papers)Nature Medicine (7 papers)Gene Therapy (7 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Manfred Schmidt
219 papers receiving 24.3k citations
Manfred Schmidt's Hit Papers
Peers
Comparison fields: 5 of 139
- Genetics 13.3k
- Genetics 1.7k
- Hematology 2k
- Virology 570
- Immunology 1.9k
Countries citing papers authored by Manfred Schmidt
This map shows the geographic impact of Manfred Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Schmidt more than expected).
Fields of papers citing papers by Manfred Schmidt
This network shows the impact of papers produced by Manfred Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Schmidt. The network helps show where Manfred Schmidt may publish in the future.
Co-authors
The 25 scholars most cited alongside Manfred Schmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 222 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 Hit paper breakdown → | 2003 | 2928 |
| 2 | A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency Hit paper breakdown → | 2003 | 1495 |
| 3 | Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy Hit paper breakdown → | 2009 | 1238 |
| 4 | Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients Hit paper breakdown → | 2008 | 1062 |
| 5 | Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy Hit paper breakdown → | 2013 | 1017 |
| 6 | Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome Hit paper breakdown → | 2013 | 890 |
| 7 | Dissecting the genomic complexity underlying medulloblastoma Hit paper breakdown → | 2012 | 705 |
| 8 | Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease Hit paper breakdown → | 2010 | 671 |
| 9 | Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration Hit paper breakdown → | 2006 | 594 |
| 10 | 2004 | 541 | |
| 11 | 2002 | 540 | |
| 12 | The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy Hit paper breakdown → | 2009 | 490 |
| 13 | Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity Hit paper breakdown → | 2014 | 477 |
| 14 | 2010 | 440 | |
| 15 | 2011 | 437 | |
| 16 | 2006 | 381 | |
| 17 | 2014 | 303 | |
| 18 | 2006 | 288 | |
| 19 | 2007 | 283 | |
| 20 | 2013 | 279 |
About Manfred Schmidt
Manfred Schmidt is a scholar working on Genetics, Genetics, Hematology, Immunology and Molecular Biology, having authored 222 papers that have together received 25.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (168 papers), Hematopoietic Stem Cell Transplantation (17 papers), CRISPR and Genetic Engineering (13 papers), Hemoglobinopathies and Related Disorders (11 papers), T-cell and B-cell Immunology (8 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Pluripotent Stem Cells Research (7 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Genetics (13.3k citations), Genetics (1.7k citations), Hematology (2k citations), Virology (570 citations) and Immunology (1.9k citations). Manfred Schmidt has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Christof V. Kalle, Cynthia C. Bartholomae, Hanno Glimm, Salima Hacein‐Bey‐Abina, Ali Nowrouzi, Alain Fischer, Marina Cavazzana, Luigi Naldini, Christopher C. Fraser and Françoise Le Deist. Their work appears in journals such as Molecular Therapy, Blood, Human Gene Therapy, Nature Medicine and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.